| Literature DB >> 19727538 |
Astrid Vollebregt1, Annet Troelstra, C Huub van der Vaart.
Abstract
INTRODUCTION AND HYPOTHESIS: The use of vaginally implanted polypropylene meshes in the treatment of prolapse is becoming increasingly popular. We set out to detect how often bacterial colonisation of the mesh occurs and if the intraoperative sterility procedures that are applied matter.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19727538 PMCID: PMC2762530 DOI: 10.1007/s00192-009-0951-5
Source DB: PubMed Journal: Int Urogynecol J Pelvic Floor Dysfunct
Patients characteristics
| Characteristics | Method 1 ( | Method 2 ( |
|
|---|---|---|---|
| Age (years, mean ± SD) | 61 (11) | 59 (10) | 0.57 |
| BMI (kg/m2, mean ± SD) | 26 (5) | 26 (5) | 0.76 |
| Previous prolapse surgery, numbers (%) | 20 (54) | 17 (63) | |
| Anaesthesia, numbers (%) | 0.68 | ||
| General | 18 (49) | 14 (52) | |
| Regional | 19 (51) | 13 (48) | |
| Surgery, numbers (%) | 0.64 | ||
| Anterior repair | 21 (57) | 14 (52) | |
| Posterior repair | 13 (35) | 12 (44) | |
| Combined repair | 3 (8) | 1 (4) | |
| Blood loss (ml, mean ± SD) | 68 (±58) | 75 (±44) | 0.59 |
| Operating time (min, mean ± SD) | 39 (±12) | 42 (±12) | 0.27 |
| Time of mesh exposure (mean ± SD) | 20 (±9) | 18 (±4) | 0.42 |
| Complications, numbers (%) | 0.63 | ||
| Peroperative | 0 (0) | 0 (0) | |
| Postoperative | |||
| Hematoma | 2 (5) | 1 (4) | 0.75 |
| Fever | 0 (0) | 3 (11) | 0.07 |
| Mesh erosion | 2 (5) | 1 (4) | 0.75 |
Culture results from the central part of the implant
| Bacterial species | None | <10 CFU | 10–100 CFU | >100–<1,000 CFU |
|---|---|---|---|---|
| Non-pathogenic species | ||||
| Coagulase-negative | 17(25.4) | 34(50.7) | 16(23.9) | – |
|
| 52(77.6) | 3(4.5) | 12(17.9) | – |
|
| 55(82.1) | 7(10.4) | 5(7.5) | – |
|
| 55(82.1) | 8(11.9) | 3(4.5) | 1(1.5) |
| Group B | 66(98.5) | 1(1.5) | – | – |
| Group C, D, G streptococci | 60(89.6) | 5(7.5) | 1(1.5) | 1(1.5) |
|
| 66(98.5) | 1(1.5) | – | – |
| Potential pathogenic species | ||||
|
| 65(97) | 1(1.5) | 1(1.5) | – |
| Yeast | 67(100) | – | – | – |
|
| 64(95.5) | 3(4.5) | – | – |
|
| 67(100) | – | – | – |
|
| 65(97) | 1(1.5) | 1(1.5) | – |
|
| 66(98.5) | 1(1.5) | – | – |
|
| 66(98.5) | 1(1.5) | – | – |
Values are presented as numbers (%)
Relationship between type of sterility procedures and bacterial growth on the mesh
| Bacterial species | Method 1 ( | Method 2 ( |
|
|---|---|---|---|
| Non-pathogenic species | |||
| Coagulase-negative | 31 (77.5) | 19 (70.4) | 0.13 |
|
| 8 (20.0) | 7 (25.9) | 0.16 |
|
| 7 (17.5) | 5 (18.5) | 0.55 |
|
| 6 (15.0) | 6 (22.2) | 0.58 |
| Group B | 1 (2.5) | 0 (0) | 0.41 |
| Group C, D, G streptococci | 2 (5.0) | 5 (19.5) | 0.25 |
|
| 1 (2.5) | 0 (0) | 0.41 |
| Potential pathogenic species | |||
|
| 1 (2.5) | 1 (3.7) | 0.34 |
| Yeast | – | – | – |
|
| 1 (2.5) | 2 (7.4) | 0.34 |
|
| – | – | – |
|
| 0 (0) | 2 (7.4) | 0.22 |
|
| 1(2.5) | 0(0) | 0.41 |
|
| 1(2.5) | 0(0) | 0.41 |
Values are presented as numbers (%)
Relationship between site of implant and bacterial growth
| Bacterial species | Anterior ( | Posterior ( |
|
|---|---|---|---|
| Non-pathogenic species | |||
| Coagulase-negative | 33 (84.6) | 17 (60.7) | 0.03* |
|
| 5 (12.8) | 10 (35.7) | 0.09 |
|
| 9 (22.5) | 3 (11.1) | 0.41 |
|
| 10 (25.6) | 2 (7.2) | 0.23 |
| Group B | 1 (2.6) | 0 (0) | 0.39 |
| Group C, D, G streptococci | 6 (15.5) | 1 (3.6) | 0.45 |
|
| 0 (0) | 1 (3.7) | 0.22 |
| Potential pathogenic species | |||
|
| 1 (2.6) | 1 (3.6) | 0.35 |
| Yeast | – | – | – |
|
| 2 (5.1) | 1 (3.6) | 0.76 |
|
| – | – | – |
|
| 0 (0) | 2 (7.2) | 0.24 |
|
| 0 (0) | 1 (3.6) | 0.23 |
|
| 1 (2.6) | 0 (0) | 0.39 |
Values are presented as numbers (%)
*p < 0.05 with Pearson chi-square test